China Reports Highest Coronovirus Cases Since April: Live Update | news

Hello and welcome to Al Jazeera’s continued coverage of the coronovirus epidemic. I am Kate Mayberry In Kuala Lumpur.

  • Mainland China has reported 101 new cases of coronavirus – the highest number in three and a half months. Of the new cases, 89 are in the far western region of Xinjiang.
  • The $ 1 trillion coronavirus relief plan is under discussion in the United States Congress, but the only element Republicans and Democrats can agree on is a $ 1200 lump sum payment for all Americans. The country’s death toll – the highest in the world – is closing at 150,000.
  • More than 16.6 million people worldwide have been diagnosed with coronovirus. According to Johns Hopkins University statistics, about 9.7 million patients have been recovered and approximately 659,000 people have died.

Here are the latest updates:

Wednesday, July 29

02:40 GMT – Modern vaccine did a good job in monkeys: study

According to a study published in the New England Journal of Medicine, Modern’s experimental COVID-19 vaccine worked well in monkeys and prevented the virus from replicating in their nose and lungs.

In a modern study, three groups of eight rhesus monkeys received either a vaccine or a placebo at two different doses.

All those who were given the vaccine developed high-level antibodies to attack parts of the SARS-CoV-2 virus. Scientists said the vaccine was also found at low doses, which produced more antibodies than those recovering from the virus, and appeared to stimulate an immune response from so-called T-cells.

The study also found that two days after the vaccinated monkeys the COVID-19 virus came through the nose and directly into the lung, no replication virus was detected in the lungs of seven of the eight animals, given the dose Were despite. Looking at the placebo was still the virus.

None of the animals exposed to high doses of the vaccine had detected the risk of the virus.

“This is the first experimental COVID-19 vaccine tested in a non-human primate, shown to produce such rapid viral control in the upper airways,” said the National Institutes of Health, which used the vaccine Is co-developing.

02:10 GMT – Hong Kong is on the verge of a big outbreak

Hong Kong leader Carrie Lam is warning that the city is on the verge of a massive outbreak of coronovirus.

New measures to prevent the spread of the virus came into force Wednesday, banning the gathering of more than two people, closing restaurants for all, and wearing mandatory masks.

Quarantine measures have also been tightened for ship and airline employees.

The Star Ferry arrives in Kowloon from Hong Kong Island. Masks are now mandatory in the region [Anthony Wallace/AFP]

01:55 GMT – Queensland off-limits to people in Sydney area

The head of the northern Australian state of Queensland, Annastasia Palaszukuk, says the state will be closed to people from the Sydney region by early Saturday.

Queensland residents returning home will also be required to spend 14 days in hotel quarantine at their own expense.

01:15 GMT – China reports the most new cases since mid-April

The National Health Commission of China has recently announced the latest coronovirus data for the country.

It has reported 101 new cases – 68 already – the highest since mid-April.

89 of the new cases were found in the far western region of Xinjiang, where large-scale trials are underway.

00:30 GMT – Australia deploys emergency response team in nursing homes

The Australian Medical Assistance Team (AUSMAT) has been deployed to nursing homes in Melbourne, which are at the center of an existing coronavirus outbreak in the state of Victoria.

AUSMAT teams are usually sent to disaster areas and include doctors, nurses, paramedics, radiographers and pharmacists.

National Deputy Chief Medical Officer Nick Coatsworth told ABC Television that there were more than 679 active cases involving home care, and that “it was important to get these outbreaks under control as soon as possible”.

Local media say Victoria is expected to announce around 295 cases on Wednesday.

00:00 GMT – Conflict in Congress over relief scheme

Republican and Democrat congresses in the United States are divided by the $ 1 trillion coronavirus aid package that Republicans announced on Monday.

Under the scheme, Unemployment benefits will be cut by only $ 200 a week, with a detailed $ 600 a week before the relief measures are set to end on Friday.

Senate Majority Leader Mitch McConnell touted the proposal as a “coherent and targeted” plan that would give $ 1,200 direct payment to many Americans, provide loans to small businesses and help reopen schools .

While Democrats agree on the payment, they say the package itself is too limited, and too late. Some Republicans say it is too expensive.

You can read more here.


Democrats and Republicans in US Congress split into a new coronovirus relief plan [Tom Brenner/Reuters]

23:30 GMT (Tuesday) – MSF asks Cepheid to drop price of coronovirus test

Support group Doctors Without Borders (Medecins Sans Frontieres, or MSF) urges US diagnostics firm Safehead to “refrain from keeping epidemic” and to cut the price of its COVID-19 trial (Xpert Xpress SARS-CoV-2) Used to be. From $ 20 per test, about $ 20 it currently charges in the world’s poorest countries.

“It is unavoidable to benefit in this epidemic,” said Sharonan Lynch, senior HIV and TB consultant for MSF’s REACH campaign. He said, “There is no time to fix the price according to the market. This critical test should be accessible to all those who need an immediate $ 5 per test to deal with this global health emergency. “

The MSF said that its research suggests the tests can be sold at a profit for $ 5 each.

Medical Coordinator Dr. Greg Alder said, “As countries are struggling to deal with suspected COVID-19 cases, an accurate rapid diagnostic test is necessary for real-time management of those affected by the virus.” MSF access campaign. “So many lives could be saved if corporations like Sefade made their tests available immediately and in all countries.”

Cepheid developed the Xpert Xpress SARS-CoV-2 cartridge with $ 3.7 million in public funds from the US government’s Biomedical Advanced Research and Development Authority. The test results in less than an hour.

Read all the updates from 28 July (tomorrow) here.


Leave a Reply

Your email address will not be published.